Metaanalyse
Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials
Current Pharmacology Reports · 26.03.2026 · 12 (1)
DOI: 10.1007/s40495-026-00451-4 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Current Pharmacology Reports, online erschienen am 26.03.2026. Verfasst von Babak Ghadirzadeh und 2 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ghadirzadeh, B., Afshar, M., & Moradi, Y. (2026). Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials. Current Pharmacology Reports, 12(1). https://doi.org/10.1007/s40495-026-00451-4
Vancouver
Ghadirzadeh B, Afshar M, Moradi Y. Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials. Current Pharmacology Reports. 2026;12(1). doi:10.1007/s40495-026-00451-4
BibTeX
@article{Ghadirzadeh2026,
author = {Ghadirzadeh, Babak and Afshar, Maziar and Moradi, Yousef},
title = {Tocilizumab and COVID-19 Outcomes: An Updated Meta-Analysis of Randomized Controlled Trials},
journal = {Current Pharmacology Reports},
year = {2026},
volume = {12},
number = {1},
doi = {10.1007/s40495-026-00451-4}
}
EUVIMED